Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000372743

Medchemexpress LLC IK-930 | 2563892-44-2 | C19H19F3N4O2S | 200 MG
SDP

Catalog No. 5000372743
Encompass_Preferred

IK-930 is a potent and orally active inhibitor of TEAD, exhibiting an EC50 value of less than 0.1 μM. It has been evaluated in vivo, demonstrating favorable pharmacokinetic properties in BALB/c mice with a Cmax of 1088 ng/mL and an AUC 0-last of 4581 ng*h/mL when administered orally at 10 mg/kg. The compound is being investigated in clinical trials for solid tumors, including those with NF2 deficiency and YAP1 or TAZ gene fusions.

  • Potent TEAD inhibitor with an EC50 < 0.1 μM.
  • Orally active.
  • Demonstrates good pharmacokinetic parameters in animal models.
  • Currently in clinical trials for various solid tumors, including those linked to NF2 deficiency and YAP1/TAZ gene fusions.

Catalog No. 50-003-72743 Supplier Medchemexpress LLC Supplier No. HY153585200MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

IK-930 is a potent and orally active inhibitor of TEAD, exhibiting an EC50 value of less than 0.1 μM. It has been evaluated in vivo, demonstrating favorable pharmacokinetic properties in BALB/c mice with a Cmax of 1088 ng/mL and an AUC 0-last of 4581 ng*h/mL when administered orally at 10 mg/kg. The compound is being investigated in clinical trials for solid tumors, including those with NF2 deficiency and YAP1 or TAZ gene fusions.

  • Potent TEAD inhibitor with an EC50 < 0.1 μM.
  • Orally active.
  • Demonstrates good pharmacokinetic parameters in animal models.
  • Currently in clinical trials for various solid tumors, including those linked to NF2 deficiency and YAP1/TAZ gene fusions.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.